dual gip/glp-1 receptor agonist GLP1-GIP co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Potential Use of GLP-1 and

Some compounding pharmacies and distributors claim they can still sell these products if theyre customized to customers specific health needs (this is actually the usual function of compounding pharmacies)

doi: 10.2337/db14-0100

The GLPs started with the brilliant Dr

One of the central considerations in the translational trajectory of GLP-1RAs is their CNS pharmacokinetics

It can involve insulin resistance, higher androgen levels, acne, facial hair growth, irregular ovulation, weight gain, inflammation, cholesterol changes, blood sugar problems, fatty liver risk, and increased cardiovascular risk

Amylin: pharmacology, physiology, and clinical potential